Simvastatin improves olanzapine-induced dyslipidemia in rats through inhibiting hepatic mTOR signaling pathway

导出原文传递学术成果认领

作者单位 School of Pharmaceutical Sciences, Southwest University, Chongqing 400715, China;Engineer Research Center of Chongqing Pharmaceutical Process and Quality Control,Chongqing 400715, China ^[1] School of Pharmaceutical Sciences, Southwest University, Chongqing 400715, China ^[2] School of Medicine, University of Wollongong, Wollongong 2522 NSW, Australia;Antipsychotic Research Laboratory, Illawarra Health and Medical Research institute, Wollongong 2522 NSW, Australia ^[3]

关键词 olanzapine dyslipidemia simvastatin SREBP1c de novo fatty acid synthesis mTOR signaling pathway

栏目名称 Pulmonary,Hepatic, and Renal Pharmacology

发布时间 2019-10-12

基金项目

grants from the Key Program of Chongqing Science and Technology Research Project Venture & Innovation Support Program for Chongqing Overseas Returnees the Fundamental Research Funds for the Central Universities,China (No.XDJK2018B037).Chao Deng was supported by a NHMRC (National Health and Medical Research Council) project grant

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0
被引2
下载0

中国药理学报（英文版）

2019年40卷8期

1049-1057页

SCIMEDLINEISTICCSCDCABP

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Simvastatin improves olanzapine-induced dyslipidemia in rats through inhibiting hepatic mTOR signaling pathway

中国药理学报（英文版）

相似文献

中国药理学报（英文版）

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Simvastatin improves olanzapine-induced dyslipidemia in rats through inhibiting hepatic mTOR signaling pathway

中国药理学报（英文版）

相似文献

中国药理学报（英文版）

相关期刊

检索历史清除